![Mary Reumuth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Reumuth
No open positions remaining
Net worth: - $ as of 31/05/2026
Profile
Mary E.
Reumuth worked as an Auditor at Ernst & Young LLP.
Served as Manager-External Financial Reporting at Genzyme Corp.
Worked as Finance Director at Verenium Corp.
from 2007 to 2011.
Held the position of Controller at Enobia Pharma, Inc. from 2011 to 2012.
Was Vice President-Finance & Controller at Kala Bio, Inc. from 2014 to 2017.
Served as Independent Director at Olink Holding AB from 2022 to 2024.
Completed undergraduate education at Texas A&M University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KALA BIO, INC. -.--% | 23/10/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Former positions of Mary Reumuth
| Companies | Position | End |
|---|---|---|
| KALA BIO, INC. | Director of Finance/CFO | 23/11/2025 |
| OLIK HLDG | Director/Board Member | 01/08/2024 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Comptroller/Controller/Auditor | 01/06/2012 |
| VERENIUM CORP | Director of Finance/CFO | 01/03/2011 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
Training of Mary Reumuth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
Olink Holding AB
 Olink Holding AB BiotechnologyHealth Technology Develops proteomics platform | Health Technology |
- Stock Market
- Insiders
- Mary Reumuth
Choose MarketScreener 
